1. Home
  2. EUDA vs INKT Comparison

EUDA vs INKT Comparison

Compare EUDA & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EUDA Health Holdings Limited

EUDA

EUDA Health Holdings Limited

N/A

Current Price

$17.29

Market Cap

52.8M

Sector

Finance

ML Signal

N/A

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

N/A

Current Price

$8.61

Market Cap

53.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EUDA
INKT
Founded
2021
2017
Country
Singapore
United States
Employees
N/A
N/A
Industry
Blank Checks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.8M
53.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
EUDA
INKT
Price
$17.29
$8.61
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $44.00
AVG Volume (30 Days)
★ 39.8K
10.2K
Earning Date
12-19-2023
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$299.28
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$8.48
52 Week High
$25.70
$15.27

Technical Indicators

Market Signals
Indicator
EUDA
INKT
Relative Strength Index (RSI) 58.32 33.82
Support Level $12.79 N/A
Resistance Level $17.50 $11.92
Average True Range (ATR) 1.21 0.73
MACD 0.16 -0.12
Stochastic Oscillator 89.21 10.85

Price Performance

Historical Comparison
EUDA
INKT

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Share on Social Networks: